Skip to main content
Smart Investors Daily
TC

OTC · TCGGY

Tecan Group AG

Healthcare · Medical - Instruments & Supplies

$61.41

Up+$8.91 (+16.97%)

Updated Nov 4, 2026, 8:58 PM

SID Score

4.9/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
2.29B
P/E ratio
25.67
Dividend yield
1.20%
52-week range
— – —
Volume
100
Avg. volume
3.36

Price performance · TCGGY

TCGGY price history

1M range · 0 trading sessions · Daily adjusted prices

TCGGY does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest TCGGY news

The latest Smart Investors Daily articles mentioning TCGGY.

TCGGY research

Overview

Company profile and research snapshot.

Company profile

TECAN GROUP AG U/ADR

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
TCGGY recent ratings
DateFirmRatingTarget
Sep 21, 2026BERENBERGBuy—
Aug 11, 2026ODDO BHFBuy—
Jul 14, 2026BERENBERGBuy—
Jul 13, 2026BERENBERGBuy—
Jun 23, 2026ODDO BHFBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 30, 2026

Tecan Group (SWX:TECN) Stock Could Be A Bargain On Its 92% Run

Tecan Group has put in a powerful run this year, and the share price now asks investors to judge whether the underlying cash flows are strong enough to support that kind of enthusiasm. With the stock sharply higher, the key issue is how today’s valuation lines up with what the business is likely to generate in hard cash over time. The share price is up 92.5% year to date, so a lot now hangs on whether the current level can be explained by the cash the business is expected to produce. Recent...

Yahoo · Oct 3, 2026

Tecan Group Stock Sees Modest Fair Value Lift After Analyst Target Increases

Tecan Group is back in focus after analysts lifted their fair value estimate from CHF 184.10 to CHF 195.73, reflecting updated price targets across recent research. Several firms have adjusted targets between CHF 151 and CHF 240, with some raising price goals without changing ratings. This helps explain the higher fair value used in current models. As you read on, you will see how these shifting targets fit into the wider Tecan Group narrative and what to watch as new updates arrive. Stay...

Yahoo · Sep 10, 2026

Tecan to participate in upcoming Investor Conference

Männedorf, Switzerland, September 10, 2026 – The Tecan Group (SIX Swiss Exchange: TECN) today announced that it will participate in the following investor conference next week: 24th Annual Morgan Stanley Healthcare Conference, New York, USADate: September 14, 2026Time: 2:35pm EDT (8:35pm CEST)Format: Fireside chat with Monica Manotas, CEO, and the Morgan Stanley analystAdditional participants: Camila Japur, CFO & Martin Braendle, SVP, Corp. Comm. & Investor RelationsWebcast live under the "Inves

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.